Tuesday, July 16, 2024

Medications on Iran’s Official Drug List Crucial for Patient Safety and Effective Treatment

Similar articles

The Secretary of the Committee for Reviewing and Compiling Iran’s Drug List, Nazila Yousefi, has advised physicians to refrain from prescribing medications that are not included in the country’s official drug list, as it confuses patients. This announcement highlights the importance of adhering to the established drug list, which is designed to ensure that all prescribed medications have undergone rigorous evaluation for their effectiveness and cost-effectiveness.

According to Mehr News Agency, Yousefi explained that the official drug list of Iran includes medications that have proven their effectiveness and cost-effectiveness through comprehensive scientific evaluations conducted by specialized committees. These evaluations are based on both foreign and domestic documentation, ensuring that the medications meet high standards. The official list is structured to meet the therapeutic needs of the vast majority of patients in the country, making it a reliable resource for healthcare providers.

Yousefi added that the national drug supply system is focused on providing the medications listed in the official drug list. This system ensures that these drugs are readily available and accessible to patients, supporting a consistent and reliable supply chain. By focusing on these approved medications, the healthcare system aims to provide effective treatment options that are both safe and economically feasible.

Medications Must Adhere to Iran’s Official Drug List to Ensure Safety and Compliance

Nazila Yousefi further stressed that physicians should avoid prescribing medications that are not included in the official list as long as the approved drugs from the list are available. These unlisted medications have not undergone the necessary approval processes and may not meet the stringent standards set by the regulatory authorities. Prescribing such medications can lead to confusion and potential harm for patients, who may not receive the appropriate treatment they need.

Yousefi emphasized that prescribing drugs outside Iran’s official drug list is considered a violation according to the law. This legal framework is in place to ensure that all prescribed medications have been thoroughly vetted for safety and efficacy. Physicians are expected to adhere strictly to the official drug list, and deviations from this list are only permitted under specific circumstances.

One such circumstance is when none of the listed drugs meet the patient’s therapeutic needs. In these exceptional cases, if there is strong evidence supporting the effectiveness of an unlisted drug for the specific indication required by the patient, a physician may consider prescribing it. However, these cases are rare and must be backed by solid evidence to justify the use of unlisted medications.


Adhering to Iran’s Official Drug List Ensures Patient Safety and Consistent Treatment Outcomes

The emphasis on adhering to the official drug list is not just about compliance with regulations but also about ensuring the best possible outcomes for patients. By following the established list, physicians can provide treatments that have been proven to work, minimizing the risk of ineffective or harmful medications being prescribed. This approach also helps to maintain consistency in treatment protocols across the country, contributing to a more reliable and efficient healthcare system.

The official drug list is designed to cover a wide range of therapeutic needs, ensuring that the majority of patients can receive effective treatments. However, there are instances where patients may have unique needs that are not fully addressed by the listed medications. In such cases, it is crucial for physicians to thoroughly evaluate the available options and make informed decisions based on the best available evidence.

You can follow our news on our Telegram and LinkedIn accounts.

Yousefi’s remarks highlight the importance of continuous evaluation and updating of the official drug list. As new medications are developed and new evidence emerges, the list must be updated to reflect these advancements. This dynamic approach ensures that patients always have access to the most effective and up-to-date treatments.

Rigorous Scrutiny and Adherence to Iran’s Official Drug List for Effective Patient Care

The process of adding new medications to the list involves rigorous scientific scrutiny to ensure that they meet the high standards of effectiveness and cost-effectiveness. This ensures that any new additions to the list are genuinely beneficial for patients and provide value for the healthcare system.

Adherence to Iran’s official drug list is crucial for maintaining a high standard of care in the healthcare system. By ensuring that all prescribed medications have been thoroughly evaluated for their safety and efficacy, the healthcare system can provide effective and reliable treatments for patients. The emphasis on following the official list also helps to minimize the risks associated with unlisted medications, ensuring that patients receive the best possible care.

Physicians play a vital role in this process by adhering to the official list and only considering unlisted medications in exceptional cases with strong evidence of their effectiveness. This approach not only ensures compliance with regulations but also supports the overall goal of providing high-quality healthcare to all patients in Iran.


Resource: Mehr News Agency, June 30, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article